Evaluation of GREM1 and THBS2 as prognostic markers in in non-small cell lung cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00432-023-04746-7.pdf
Reference19 articles.
1. Alexander M, Kim SY, Cheng H (2020) Update 2020: management of non-small cell lung cancer. Lung 198(6):897–907
2. Broderick SR (2020) Adjuvant and neoadjuvant immunotherapy in non-small cell lung cancer. Thorac Surg Clin 30(2):215–220
3. Duma N, Santana-Davila R, Molina JR (2019) Non-small cell lung cancer: epidemiology, screening, diagnosis, and treatment. Mayo Clin Proc 94(8):1623–1640
4. Hsu ML, Naidoo J (2020) Principles of immunotherapy in non-small cell lung cancer. Thorac Surg Clin 30(2):187–198
5. Jiang YM, Yu DL, Hou GX, Jiang JL, Zhou Q, Xu XF (2019) Serum thrombospondin-2 is a candidate diagnosis biomarker for early non-small-cell lung cancer. Biosci Rep. https://doi.org/10.1042/BSR20190476
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Changes in the expression of cell interaction-related pathways during brain metastasis in lung adenocarcinoma: Gene expression and immunohistochemical analysis;Pathology - Research and Practice;2024-08
2. Insight into the Role of the miR-584 Family in Human Cancers;International Journal of Molecular Sciences;2024-07-06
3. Heterozygous THBS2 pathogenic variant causes Ehlers–Danlos syndrome with prominent vascular features in humans and mice;European Journal of Human Genetics;2024-03-04
4. PLAU and GREM1 are prognostic biomarkers for predicting immune response in lung adenocarcinoma;Medicine;2024-02-02
5. Systematic analysis of integrated bioinformatics to identify upregulated THBS2 expression in colorectal cancer cells inhibiting tumour immunity through the HIF1A/Lactic Acid/GPR132 pathway;Cancer Cell International;2023-10-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3